|
Q4 FY2026
As of Jun 30, 2026
|
Q3 FY2026
As of Mar 31, 2026
|
Q2 FY2026
As of Dec 31, 2025
|
Q1 FY2026
As of Sep 30, 2025
|
Q4 FY2025
As of Jun 30, 2025
|
Q3 FY2025
As of Mar 31, 2025
|
Q2 FY2025
As of Dec 31, 2024
|
Q1 FY2025
As of Sep 30, 2024
|
Q4 FY2024
As of Jun 30, 2024
|
Q3 FY2024
As of Mar 31, 2024
|
Q2 FY2024
As of Dec 31, 2023
|
Q1 FY2024
As of Sep 30, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | ||||||||||||
| Accounts receivable, net | ||||||||||||
| Due from related party | ||||||||||||
| Prepaid expenses | ||||||||||||
| Other current assets | ||||||||||||
| Total current assets | ||||||||||||
| Due from related party, net of current portion | ||||||||||||
| Operating lease right-of-use assets | ||||||||||||
| Property and equipment, net | ||||||||||||
| Other non-current assets | ||||||||||||
| Software | ||||||||||||
| Intangible assets, net | ||||||||||||
| Goodwill | ||||||||||||
| Total assets | ||||||||||||
| Current liabilities: | ||||||||||||
| Accounts payable | ||||||||||||
| Accounts payable - related party | ||||||||||||
| Loan from officer | ||||||||||||
| Accrued liabilities | ||||||||||||
| Deferred wages payable | ||||||||||||
| Accrued interest expense | ||||||||||||
| Convertible debentures | ||||||||||||
| Convertible debentures - short term | ||||||||||||
| Loans payable, current portion | ||||||||||||
| Right of use liability, current portion | ||||||||||||
| Advances from related party | ||||||||||||
| Total current liabilities | ||||||||||||
| Accrued interest payable | ||||||||||||
| Convertible debentures | ||||||||||||
| Loans payable, net of current portion | ||||||||||||
| Right of use liability | ||||||||||||
| Retirement benefit obligation | ||||||||||||
| Deferred tax liability | ||||||||||||
| Total liabilities | ||||||||||||
| Stockholders' equity: | ||||||||||||
| Preferred stock, $0.001 par, 10,000,000 shares authorized, no shares issued and outstanding as of both June 30, 2026 and December 31, 2025 | ||||||||||||
| Common stock, $0.001 par, 75,000,000 shares authorized, 34,564,312 and 21,663,312 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||
| Additional paid-in capital | ||||||||||||
| Subscriptions receivable | ||||||||||||
| Accumulated other comprehensive income | ||||||||||||
| Accumulated deficit | ||||||||||||
| Total stockholders' equity (deficit) | ||||||||||||
| Total liabilities and stockholders' equity (deficit) |
Loading...
